Cambridge Investment Research Advisors, Inc.

Position in TXG — 10x Genomics, Inc.

CIK 1419186 FAIRFIELD, IA

Position in TXG

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$4,324,291

+$2,455,139 QoQ

Shares Held

112,788

+28.1% QoQ

Ownership

0.087%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#89

of 389 holders

Holding Since

Dec 2020

13 quarters on record

Healthcare · as of Jun 30, 2026

Cambridge Investment Research Advisors, Inc. holds $98,409,731 across 28 Medical Devices names. TXG ranks #5 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	299,079	$27,138,428
2	SYK	Stryker Corp	73,172	$23,037,472
3	MDT	Medtronic plc	241,056	$18,857,810
4	GEHC	GE HealthCare Technologies Inc.	82,290	$5,267,382
5	TXG	10x Genomics, Inc. This page	112,788	$4,324,291
6	EW	Edwards Lifesciences Corp	45,749	$4,138,454
7	DXCM	Dexcom Inc	45,009	$3,031,356
8	BSX	Boston Scientific Corp	51,066	$2,179,496

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,324,291	112,788	+28.1%	Shares	Sole	2026-07-30
2026-03-31	$1,869,152	88,043	+10.0%	Shares	Sole	2026-04-30
2025-12-31	$1,304,848	80,003	+37.9%	Shares	Sole	2026-02-05
2025-09-30	$678,242	58,019	+430.4%	Shares	Sole	2025-11-12
2025-06-30	$126,662	10,938	-58.8%	Shares	Sole	2025-07-31
2025-03-31	$231,921	26,566	-21.6%	Shares	Sole	2025-04-22
2024-12-31	$486,775	33,898	+8.0%	Shares	Sole	2025-02-14
2024-09-30	$709,012	31,400	+2053.6%	Shares	Sole	2024-10-28
2021-12-31	$217,183	1,458	+3.4%	Shares	Sole	2022-02-03
2021-09-30	$205,267	1,410	+5.9%	Shares	Sole	2021-11-02
2021-06-30	$260,832	1,332	+5.5%	Shares	Sole	2021-08-10
2021-03-31	$228,603	1,263	-47.0%	Shares	Sole	2021-05-07
2020-12-31	$337,716	2,385	—	Shares	Sole	2021-02-04
No filing history on record for this holder in this stock.